on semaglutide Week 2 Semaglutide: Injection Day for PCOS Not losing weight on semaglutide?

Its available if you meet the eligibility criteria for referral to a specialist weight management service, like Oviva

Pain: Your skin is more sensitive to heat because its nerve fibers are activated, causing pain

Yes, thigh injections deliver semaglutide into subcutaneous tissue with identical absorption and effectiveness as abdominal injections

Semaglutide Technical Profile Classification: Selective GLP-1 (glucagon-like peptide-1) receptor agonist CAS Number: 910463-68-2 Molecular Weight: 4113.58 g/mol Peptide Length: 31 amino acids Structural Basis: 94% sequence homology to native human GLP-1(7-37) Half-Life Extension: C-18 fatty diacid chain conjugated to Lys26 via a mini-PEG linker, enabling non-covalent albumin binding in circulation DPP-4 Resistance: Aib (alpha-aminoisobutyric acid) substitution at position 8 prevents enzymatic cleavage by dipeptidyl peptidase-4 Receptor Target: GLP-1 receptor (GLP-1R) exclusively Tirzepatide Technical Profile Classification: Dual GIP/GLP-1 receptor agonist (first-in-class) CAS Number: 2023788-19-2 Molecular Weight: 4813.45 g/mol Peptide Length: 39 amino acids Structural Basis: Built on the native GIP (glucose-dependent insulinotropic polypeptide) peptide backbone, engineered with GLP-1R cross-reactivity Half-Life Extension: C-20 fatty diacid moiety for albumin binding, providing an extended research half-life Receptor Targets: GIP receptor (GIPR, primary and full agonism) AND GLP-1 receptor (GLP-1R, secondary agonism with biased signaling) The Critical Structural Difference The single most important distinction between these compounds is their receptor architecture

The dosing schedule used in clinical trialsevery seven dayswas carefully chosen to balance efficacy with tolerability